This product is an intermediate product of sugar metabolism in the body. It produces pharmacological effects by regulating the activity of several enzymes in sugar metabolism. Exogenous 1,6-diphosphate fructose can increase the concentration of adenosine triphosphate and creatine phosphate in cells, promote the influx of potassium ions, increase the content of diphosphoglycerate in red blood cells, inhibit the release of oxygen free radicals and histamine, and has many other pharmacological effects. It can reduce the damage caused by ischemia and hypoxia, especially for ischemic heart disease.

This product is an oxime compound. Its quaternary ammonium group can tend to the cationic site of the inactive phosphorylated cholinesterase that has been combined with the organophosphorus insecticide. Its nucleophilic group can directly combine with the phosphorylated group of cholinesterase and then detach from the cholinesterase together, so that the cholinesterase can be restored to its original state. It regains its vitality. The effect of rejuvenating the aged cholinesterase that has been inhibited by organophosphorus insecticides for more than 36 hours is very poor. It has no resurrection effect on the cholinesterase inhibited by chronic organic insecticide poisoning. This product has a significant effect on the nicotinic symptoms caused by organophosphorus insecticides, but a weak effect on muscarinic symptoms, and no significant effect on central nervous system symptoms.

Not clearly described

Non-digitalis cardiotonic agent with positive inotropic effect, can increase myocardial contractility, improve myocardial pump function, dilate blood vessels, reduce myocardial oxygen consumption; improve myocardial cell metabolism, protect ischemic and hypoxic myocardium; can improve sinoatrial node P cell function.